BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 7038712)

  • 1. The biological activity of the synthetic polyanion, pyran copolymer (diveema, MVE, 46015) and the heterocyclic bis DEAE fluorenone derivative, tilorone and congeners: clinical and laboratory effects of these agents as modulators of host resistance.
    Regelson W
    Pharmacol Ther; 1981; 15(1):1-44. PubMed ID: 7038712
    [No Abstract]   [Full Text] [Related]  

  • 2. [Interferonogenic and antiviral activity of the tobacco mosaic virus, tilorone and sodium nucleinate].
    Balezina TI; Fadeeva LL; Zemskov VM; Korneeva LE; Loĭdina GI
    Antibiotiki; 1976 Mar; 21(3):250-4. PubMed ID: 818948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of pyran copolymer on activation of murine macrophages: evidence for incomplete activation by use of functional markers.
    Adams DO; Johnson WJ; Marino PA; Dean JH
    Cancer Res; 1983 Aug; 43(8):3633-7. PubMed ID: 6861134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased spreading of macrophages from mice treated with interferon inducers.
    Rabinovitch M; Manejias RE; Russo M; Abbey EE
    Cell Immunol; 1977 Mar; 29(1):86-95. PubMed ID: 849607
    [No Abstract]   [Full Text] [Related]  

  • 5. Induction of interferon with low molecular weight compounds: fluorenone esters, ethers (tilorone), and pyrimidinones.
    Stringfellow DA
    Methods Enzymol; 1981; 78(Pt A):262-84. PubMed ID: 6173601
    [No Abstract]   [Full Text] [Related]  

  • 6. Bimodal effects of MVE-2 on cytotoxic activity of natural killer cell and macrophage tumoricidal activities.
    Piccoli M; Saito T; Chirigos MA
    Int J Immunopharmacol; 1984; 6(6):569-76. PubMed ID: 6511143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of the immunomodulator tilorone on the in vivo acetylation of procainamide in the rat.
    Svensson CK; Knowlton PW
    Pharm Res; 1989 Jun; 6(6):477-80. PubMed ID: 2474808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-interferon globulin inhibits macrophage phagocytic enhancement in vivo by tilorone or Newcastle disease virus.
    Rabinovitch M; Manejias RE
    Cell Immunol; 1978 Sep; 39(2):402-6. PubMed ID: 699064
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of antiviral properties in mice of bis-pyrrolidinoacetamido-fluorenone (MLU-B75), bis-dipropylaminoacetamido-fluorenone (MLU-B76), and tilorone hydrochloride.
    Veckenstedt A; Witkowski W; Hoffmann S
    Acta Virol; 1979 Mar; 23(2):153-8. PubMed ID: 39439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired macrophage functions as a possible basis of immunomodification by microbial agents, tilorone and dimethyldioctadecylammonium bromide.
    Bloksma N; de Reuver MJ; Willers JM
    Antonie Van Leeuwenhoek; 1983 Apr; 49(1):13-22. PubMed ID: 6351737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship of molecular weight to antiviral and antitumor activities and toxic effects of maleic anhydride-divinyl ether (MVE) polyanions.
    Morahan PS; Barnes DW; Munson AE
    Cancer Treat Rep; 1978 Nov; 62(11):1797-803. PubMed ID: 103618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the immunomodulator tilorone on the acetylation of 2-aminofluorene and DNA-2-aminofluorene adducts in the rats.
    Chung JG; Chang HL; Yeh CC; Lu HF; Chang CC; Tsai HD
    Anticancer Res; 2000; 20(1A):467-73. PubMed ID: 10769698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Future direction of synthetic polyanions (pyran copolymer).
    Regelson W
    Cancer Treat Rep; 1978 Nov; 62(11):1853-6. PubMed ID: 365328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Augmentation of natural cell activity in tumor-bearing and normal mice by MVE-2.
    Budzynski W; Chirigos M; Gruys E
    Cancer Immunol Immunother; 1987; 24(3):253-8. PubMed ID: 3594488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tilorone and related bis-basic substituted polycyclic aromatic and heteroaromatic compounds.
    Levin RH; Albrecht WL
    Prog Med Chem; 1981; 18():135-90. PubMed ID: 7045982
    [No Abstract]   [Full Text] [Related]  

  • 16. [Changes in the enzymic activity of monooxygenase components of rat hepatocytes after administration of tilorone].
    Bogatskiĭ AV; Galkin VN; Golovenko NIa; Filippova TO; Litvinova LA
    Ukr Biokhim Zh (1978); 1981; 53(6):108-10. PubMed ID: 7324184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New synthetic routes to tilorone dihydrochloride and some of its analogues.
    Burke HM; Joullié MM
    J Med Chem; 1978 Oct; 21(10):1084-6. PubMed ID: 722716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the ability of small molecular interferon inducers: tilorone and acridine drugs.
    Gláz ET; Tálas M
    Arch Virol; 1975; 48(4):375-84. PubMed ID: 1200845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of interferon-inducing activities and antiviral effects of tobacco mosaic virus, tilorone and sodium nucleinate.
    Balezina TI; Korneeva LE; Zemskov VM; Loidina GI; Nikolaeva OV; Fainshtein SL; Fadeeva LL; Eromolieva ZV
    Acta Virol; 1977 Jul; 21(4):338-43. PubMed ID: 20769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Interferon inducers].
    German A; Quero AM
    Actual Pharmacol (Paris); 1974; 27():1-22. PubMed ID: 4620125
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.